← Leaderboards
Shreya Raghavan
Texas Engineering Experiment Station
$1,127,169
Attributed
$1,245,070
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $539.3K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,245,070 · 3
By mechanism
R21$624,775 · 2
R37$620,295 · 1
Top collaborators
- Antonina I Frolova1 shared
Others in their field
Other Emerging Leaders on “Engineering”
- Lisa Garcia Bedolla · University Of California-Berkeley$175,927,128
- John E West · University Of Texas At Austin$131,399,667
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Joy Williamson-Lott · University Of Washington$69,987,326
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$62,539,586
Research focus
EngineeringBiomedical Engineering3-DimensionalIn VitroPatient ResponsePre-Clinical ModelIntestinesTechnologyTissue EngineeringInnovationColorectal CancerAdjuvant TherapyPre-ClinicalBiocompatible MaterialsSamplingScreeningValidationColon Cancer PatientsAdjuvant ChemotherapyMalignant NeoplasmsBenchmarkingPharmaceutical PreparationsPreventCells
Grant awards (5)
3D Engineered Model of Microscopic Colorectal Cancer Liver Metastasis for Adjuvant Chemotherapy Screens$303,546
R37 · FY2025 · CA · contact PI
Quantitating Oxytocin-induced Contractility in Bioengineered 3D Human Myometrium$235,803
R21 · FY2025 · HD · contact PI
3D Engineered Model of Microscopic Colorectal Cancer Liver Metastasis for Adjuvant Chemotherapy Screens$316,749
R37 · FY2023 · CA · contact PI
Engineered Enteric Nervous System-Peri Neural Invasion platform to improve predictive preclinical screens in early-stage colorectal adenocarcinomas$169,272
R21 · FY2022 · CA · contact PI
Engineered Enteric Nervous System-Peri Neural Invasion platform to improve predictive preclinical screens in early-stage colorectal adenocarcinomas$219,700
R21 · FY2021 · CA · contact PI